Centralization to fewer surgeons results in better survival after esophageal cancer surgery

Key points
- Patients who undergo surgery for oesophageal cancer have a much greater chance of long term survival if the operation is carried out by a surgeon who has performed this particular operation many times before.
- Surgery is the most widely established curative treatment for oesophageal cancer.
- Earlier studies have shown that the surgeon's and the hospital's annual operation volume both affect short-term survival (1-3 months post-surgery), but there are few patients who die so soon afterwards.
- The study that is now published in the Journal of Clinical Oncology is the most comprehensive of its kind in the subject.
Patients who undergo surgery for oesophageal cancer have a much greater chance of long term survival if the operation is carried out by a surgeon who has performed this particular operation many times before. This according to a new, large-scale study conducted by researchers at Karolinska Institutet in Sweden, and published in the Journal of Clinical Oncology. In their article, the researchers conclude that oesophageal cancer surgery should be concentrated – or centralised – to fewer surgeons.
Surgery is the most widely established curative treatment for oesophageal cancer. However, it is a major operation and only a third of patients who undergo it survive for five or more years afterwards. The purpose of the present study was to ascertain the relation between hospital and surgeon volume and long-term survival in patients who underwent surgery for oesophageal cancer.
Earlier studies have shown that the surgeon's and the hospital's annual operation volume both affect short-term survival (1-3 months post-surgery), but there are few patients who die so soon afterwards. The few studies that have examined operation volume in relation to long-term survival have given conflicting results, while many lack information on other key prognostic factors, including tumour stage.
The study that is now published in the Journal of Clinical Oncology is the most comprehensive of its kind in the subject.
It included all 1,335 patients operated on for oesophageal cancer in Sweden between 1987 and 2005 with follow-ups up to January 2011. Survival analysis was used to study the effect of annual hospital volume, annual surgeon volume and surgeon experience measured as cumulative surgeon volume as regards survival following oesophageal cancer surgery. The analyses were adjusted for all established prognostic factors.
The study's main finding is that patients operated on by surgeons with a high annual and total volume had 22 per cent lower long-term mortality than patients operated on by surgeons with a low annual and total operation volume. The hospital's annual volume, however, had no independent impact on long-term survival. From this, the researchers conclude that oesophageal cancer surgery should be concentrated to fewer surgeons, giving them the opportunity to maintain a high annual volume for this major, complicated procedure.
###
Publication: 'Hospital and surgeon volume in relation to survival after esophageal cancer surgery in a population-based study', Maryam Derogar, Omid Sadr-Azodi, Asif Johar, Pernilla Lagergren, and Jesper Lagergren, Journal of Clinical Oncology, online early release 7 January 2013. Embargoed until 7 January at 4 pm US ET.
For further information, please contact:
Maryam Derogar
Doctoral Student, MD
Tel: 46-851-770-000 (switchboard) or 46-736-778-684Email: [email protected]
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsNew protein knowledge offers hope for better cancer treatment
When the pharmaceutical industry develops new medicines – for example for cancer treatment – it is important to have detailed knowledge of the body's molecular response to the medicine. "With a better knowledge of the…
20 September 2013
NewsNew models of drug-resistant breast cancer hint at better treatments
Breast cancer that spreads to other organs is extremely difficult to treat. Doctors can buy patients time, but a cure remains elusive. Now, researchers at Washington University School of Medicine in St. Louis have shown…
20 September 2013
NewsResults of long term follow-up show breast conserving treatment with radiotherapy reduces risk of local recurrence
Results of EORTC trial 10853 appearing in the Journal of Clinical Oncology show that breast conserving treatment combined with radiotherapy reduces the risk of local recurrence in women with ductal carcinoma in situ…





